Skip to content

Source filing unavailable

Q4 2019 · —
Revenue—
Net Income-$11.68Kno prior Q4 2018 on fileN/M vs Q3 2019
EPS Diluted$0.00no prior Q4 2018 on fileN/M vs Q3 2019
Operating Income-$10,238—
Operating Cash Flowderived-$5,591,000—
Free Cash Flowderived-$5,776,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q4 2018 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Compass Therapeutics, Inc. · CIK 1738021 · Engraved from SEC EDGAR